Grifols, S.A. (GIFLF)
| Previous Close | 11.76 |
| Open | 11.76 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 11.76 - 11.76 |
| 52 Week Range | 7.90 - 21.00 |
| Volume | |
| Avg. Volume | 648 |
| Market Cap | 7.132B |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | 10.84 |
| EPS (TTM) | 1.09 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Jun 03, 2021 |
| 1y Target Est | N/A |
- Zacks
Are Investors Undervaluing Grifols (GRFS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks
Grifols (GRFS) Upgraded to Strong Buy: Here's Why
Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- Reuters
UPDATE 2-Grifols' shares tank 10% as 2023 outlook disappoints
Spanish pharmaceutical company Grifols' shares fell around 10% in afternoon trading after its 2023 outlook disappointed analysts, who were looking for a better recovery in margins. Grifols' shares were 9.6% down at 15:44 GMT and were the worst performers on the blue-chip Spanish Ibex index, which was up 0.97%. Grifols reported on Tuesday that net profit rose 10% to 208 million euros ($220.19 million).
